Term
Targets of ophthalmic pharmacotherapy |
|
Definition
Extraocular structures: conjunctiva, cornea, tears
Iris
Ciliary body and drainage angle
Lens
Vitreous and retina
Posterior orbit |
|
|
Term
Methods of medicating eye depends on: |
|
Definition
Target tissue
amount of drug needed at site
characteristics of drug
convenience and safety (o/s vs o/o; hazardous drugs
Client compliance (frequency, physical limitations)
Cost |
|
|
Term
|
Definition
Topical
Subconjunctival injection
intraocular injection
systemic
|
|
|
Term
Topical adminstration sites |
|
Definition
lids
conjunctiva
cornea
sclera
anterior uvea |
|
|
Term
Subconjunctival injection administration |
|
Definition
cornea
sclera
anterior uvea
vitreous |
|
|
Term
intraocular injection administration |
|
Definition
anterior segment
posterior segment |
|
|
Term
|
Definition
oral or parenteral
eyelids
sclera
anteroir and posterior uvea
vitreous
retina
optic nerve
orbit
limited to cornea |
|
|
Term
Topical administration
Cornea |
|
Definition
First barrier->multiple layers
lipophilic: epithelium and endothelium
hydrophilic: stroma
the first barrier is epithelium: affected by different pathologies
tear layer: combination of water and lipids |
|
|
Term
|
Definition
eyelids, conjunctival, corneal and uveal dz
two possible ways for absorption:
1. Penetration through the cornea
2. Systemic absorption through the conjunctiva and nasolacrimal duct |
|
|
Term
Topical administration
increased drug concentration |
|
Definition
1. increase frequency
2. increase concentration |
|
|
Term
|
Definition
solution/suspension (saturated solution)
easy to apply
suspension-saturated solution with poorly soluble drugs
particles seen-shake well
short contact time-75% lost through lacrimal drainage
Multiple drops administration-first drop with dilute and wash the first one->wait 5 minutes between different types of drops |
|
|
Term
Topical
Ophthalmic ointment |
|
Definition
longer contact time
reduce loss through lacrimal drainage
more stable than drops
lubricant
application is more challenging than drops (SA)
may slow down ulcer healing
Dz ex-dystechia-cause corneal ulcer, secondary infections |
|
|
Term
Topical
Effect on drug penetration and side effects |
|
Definition
pH-7.2 (5-9 tolerate)
molecule size
drug concentration
vehicle and preservatives |
|
|
Term
Topical
Subpalpebral lavage (SPL) |
|
Definition
Can be used in horses to facilitate frequent or long term treatment
more than few days
|
|
|
Term
|
Definition
very problematic
drugs interaction-pH, precipitation, stability
refrigeration
exposure to light
suspensions
He likes injection cup not a pump
if put more than 1 drug in pump->drug interaction |
|
|
Term
Fate of drugs following topical admin |
|
Definition
75% lost through lacrimal drainage
only a small amount absorbed
Absrobed through cornea->aqueous->taken up in uvea or lens or lost to aqeous outflow
penetrates conjunctiva->into/thru the sclera->uvea or lost in venous blood (no lymphatics in eye) |
|
|
Term
|
Definition
Periodic drops (topically or via SPL) or ointments
continuous lavage
soft contact lenses
extended delivery membranes
liposome
microbeads |
|
|
Term
Subconjunctival injections
Penetration: |
|
Definition
Bypass conjunctiva and cornea barriers for direct scleral absorption
Leaks back onto surface of eye->absorbed through the cornea
Only small amount absorbed into the eye but injection site has large amount of drug (depot effect) |
|
|
Term
Subconjunctival injections
how it is applied/works |
|
Definition
drug may las several days in the "depot"
no better than frequently applied topical medication
treats anterior segment of eye and vitreous |
|
|
Term
Subconjunctival injections
indications/advantages |
|
Definition
for animals that will not permit repeated topicals, wildlife
for water soluble drugs that poorly penetrat cornea
for long acting drugs (ex: methylprednisolone acetate)
to achieve high concentrations of drug for short time
confine the drug's effect to the eye |
|
|
Term
Subconjunctival injections
disadvantages |
|
Definition
cannot change medication once injected
occasionally painful due to drug or vehicles
may develop granuloma at injection site
no better than frequently administered topical medication |
|
|
Term
|
Definition
into anterior chamber or vitreous
seldom done if systemic admin works
drug/vehicle may have deleterious effect on ocular structures
should be done by ophthomologist-can damage eye |
|
|
Term
|
Definition
usually limited to regional anesthesia
drug may penetrate the posterior sclera and enter choroid
can damage the ON or globe
Can cause retrobulbar hemorrhage |
|
|
Term
Systemic administration
sites and uses |
|
Definition
Oral, IV, IM, SC
more effective when blood-ocular barrier disrupted
mostly for tx of posterior segment of eye or orbital disease |
|
|
Term
|
Definition
treat or prevent infection (pre-op) |
|
|
Term
|
Definition
choice depends on culture and sensivity or common flora
most antibiotics have poor corneal penetration
when empiric a/b tx doesn't help->culture and sensitivity->look for underplaying cause for recurrent infection
Ex: ectopic cilia, dry eye, foreign body
Not all antibiotics available topically |
|
|
Term
|
Definition
Bacitracin
Gramicidin
Polymyxin |
|
|
Term
Antibiotics
Aminoglycosides |
|
Definition
Neomycin
Gentamicin
Tobramycin |
|
|
Term
|
Definition
Ciprofloxacin
Ofloxacin
Lomefloxacin |
|
|
Term
|
Definition
Tetracyclines
Erythromycin
Chloramphenicol
Sulfonamides
Cephalosporin
Penicillin |
|
|
Term
|
Definition
Bactericidal
effective empiric tx
topical use only-toxic systemically
Usually in combos->
neomycin+polymyxin+bacitracin (NeoPolyBac)-ointment
neomycin+polymyxin+gramicidin (NeoPolyGram)-solution |
|
|
Term
|
Definition
Bacteriocidal, broad spectrum, mainly for G-
toxic systemically
epitheliotoxic
tobramycin, amikacin, gentamicin-pseudomonas (melting corneal ulcer)
Tobramycin is cheap and more effective, less epitheliotoxic than gentamycin
Neomycin variable efficacy vs pseudomonas |
|
|
Term
|
Definition
Mainly for staph/strep
well tolerated
low corneal permeability
effective vs resistant staph
no ophthalmic prep
can be compounded easily |
|
|
Term
|
Definition
Bacteriostatic, broad spectrum
inactivated in combo with discharge/topical anesthesia
limited permeability
may irritate eye
commercially available |
|
|
Term
|
Definition
Bacteriastatic, broad spectrum
well tolerated
effective against: mycoplasma and chlamydophila (kittens) rickettsia
"pink eye" cattle (mixed Moraxella bovis/Mycoplasma)
Ophthalmic prep:tetracycline Hydrochlorid Ophthalmic Ointment-sometimes in combo with other antibiotics |
|
|
Term
|
Definition
anti-inflammatory
anti-protease
faciliatates healing of indolent ulcers
Ophthalmic prep tetracycline hydrochloride ophthalmic ointment
systemic doxycycline-secrete in tears
only disadvantage-only ointment |
|
|
Term
|
Definition
Bactericidal, non-toxic
Staphy and strep
no topical prep
rare in ophtho
used for Bovine keratoconjunctivitis IBK or pink eye in cattle by subconjunctival injection |
|
|
Term
|
Definition
Broad spectrum, limited against anaerobes
use it when really needed (C&S)
|
|
|
Term
Quinolons
ophthalmic prep |
|
Definition
Ciprofloxacin
Ofloxacin
Moxifloxacin
Lomefloxacin-good corneal penetration; use for anterior segment |
|
|
Term
|
Definition
Bacteriostatic
broad spectrum
G+
not to be used in food animals
Side effects: irritation, redness, itching, aplastic anemia |
|
|
Term
|
Definition
Mycotic keratitis/keratomycosis of the horse |
|
|
Term
|
Definition
Miconazole
Natamycin
Voriconazole |
|
|
Term
|
Definition
effective against aspergillus spp and G+ cocci
aspergillus spp. common in equine eye infection
low corneal permeability
use 4-6 times/day
cheap
no commercial ophthalmic preparation-needs to be compounded as both ointment or solution |
|
|
Term
|
Definition
only commerical antifungal ophthalmic preparation
5% ophthalmic suspension
3% for SPL
effective against Fusarium spp.
Low corneal permeability
use 4-6 times/day
Expensive-amphotericin B is cheaper, less effective |
|
|
Term
|
Definition
Third generation of azole
effective against Fusarium (2nd most common in equine eyes) and Aspergillus spp.
Better corneal penetration than miconazole
use 4-6 times/day
Expensive |
|
|
Term
|
Definition
Nucleoside analogs (and interferons) are currently used in vet ophthalmology
most frequently for feline herpesvirus (<<horses)
inhibit or alter DNA synthesis
virostatic-require functional cellular immunity and Ig's in tears
unable to eradicate latent infection
expensive (new generation's) |
|
|
Term
|
Definition
effective
no commerical opthalmic prep
compounded as solution or ointment
use q 2h for 2 d, then 4-6x/day for 3-5 wks
cheap
can be very irritative-makes difficult to admin |
|
|
Term
|
Definition
Ganciclovir-same efficacy idoxuridine, double penciclovir and cidofovir
penciclovir
cidofovir-effective can be given BID (less issues with admin to a cat)
expensive
no commerical prep
Acyclovir not effective vs feline herpes |
|
|
Term
|
Definition
compounded from IV preparation
affect transcription
stimulat the immunological defense
-immune cell-mediated lysis of virus-infected cells) |
|
|
Term
|
Definition
Ties up arginine so it is not available for viral replication
add to food daily for life to limit chronic recurring infections
use 250-500 mg/cat q24h for prevetion
250-500 mg/cat q12h for active disease
available in health food stores and as prep for cats
-recommend prep for cats due to cat compliance |
|
|
Term
Anti-inflammatory corticosteroids
topical use |
|
Definition
Do not use topical steroids on an eye with ulcerative keratitis |
|
|
Term
Anti-inflammatory corticosteroids
MOA |
|
Definition
1. decrease arachidonic acid release from injured cell membranes
2. block degranulation of neutrophils, mast cells, basal cell
3. prevent protease, histamine, bradykinin release
4. reduce capillary permeability, vasodilation, neovascularization |
|
|
Term
Anti-inflammatory corticosteroids
effects |
|
Definition
reduce edema, redness and pain
reduce cellular exudation
reduce leukocyte infiltration of lesions
suppress lymphocyte proliferation
epithlial and stromal dystophy/degeneration with long term use |
|
|
Term
Anti-inflammatory corticosteroids
uses
disadvantages |
|
Definition
topical, subconjunctival, retrobulbar, systemic
increase intraocular pressure
does not cause cataracts like in people
inhibit fibrosis
interfere with epithelial regeneration
potential proteinases break down collage->corneal melting |
|
|
Term
Indication for topical steroids |
|
Definition
reduce signs of inflammation and effects
redness, swelling, pain reduced
allergy, hypersensitivity and
immune-mediate disease (chronic superficial keratitis-Pannus, granulomatous episcleritis, uveritis)
Infection-careful!!!
Trauma-careful!!!
reduce scarring-fibrosis
preventrion of inflammation pre-op |
|
|
Term
Anti-inflammatory corticosteroids
corneal penetration and dosing |
|
Definition
Corneal penetration: acetate>alcohol>phosphate
Prednisolone acetate 1.%-better corneal penetration->prefer for uveitis and intraocular inflammation
Dexamethasone Na phosphate 0.1%-more potent, longer action-poor corneal penetration, use for extraocular inflammation
Dexamethasone alcohol 0.1% for uveitis-corneal penetrate
Combo with antibiotics-hydrocortisone, dexamethasone, betamethasone
|
|
|
Term
|
Definition
Short term: dexamethasone solution, triamcinolone (Kenalog) suspension
long term: greater granuloma risk at injection site
1. betamethasone (Betasone) suspension
2. methylprednisolone (Depo-Medrol) suspension
3. Triamcinolone (Kenalog) suspension
once there cannot remove->less than ideal option |
|
|
Term
|
Definition
limited to severe intraocular inflammation, orbit, optic nerve disease
Small animals-prenisone, prednisolone PO is adequate
Horse-dexamethasone but careful-laminitis
uncommonly used |
|
|
Term
Contraindications for topical steroid use |
|
Definition
ulcerative keratitis:
-inhibit fibroblast responses
-interfere with epithelial regneration
-potientiate proteinases that break down collagen
uncontrolled/severe infections
-may use with antibiotics to block uncontrolled inflammation (blindness)
Mature scars->no point, won't help anything
Corneal degenerations
Careful with metabolic dz-diabetes, especially in small animals
may facilitate fungal infections in prolonged use
may cause epithlial and stromal dystrophy/degeneration
may increase intraocular pressure
do not cause cataracts |
|
|
Term
|
Definition
when steroids contraindicated
complimentary to corticosteroids
pre cataract surgery |
|
|
Term
|
Definition
prevent formation of prostaglandins from arachdonic acid
prostaglandins->primary mediators or ocular inflammation |
|
|
Term
|
Definition
delay healing of epithelium but not as deleterious as corticosteroids
expensive compared to steroids
Flubiprofen-0.03% ophthalmic solution
Diclofenac-0.1% ophthalmic solution
best not to use any NSAID's or topical steroids with corneal ulcer->last resort use NSAID's before steroids |
|
|
Term
|
Definition
Small animals
Carprofen (Rimadyl)
Meloxican (Metacam)
Horses:
Flunixin meglumin (Banamine)-most effective in horses; monitor kidney function long term, protect GI with omeprazole
Piroxicam-tx SCC (80-160 mg/horse/day); limited data in literature |
|
|
Term
|
Definition
used in place or in combo with corticosteroids-synergic
Cyclosporine A (optimmune) ointment 0.2%-compounded 1-2% ophthalmic solution in oil
(irritating and rarely may cause alopecia)
Tacrolimus-no ophthalmic prep
compounded 0.02%-0.03% ophthalmic solution in veg. oil |
|
|
Term
|
Definition
T lymphocyte suppressor
inhibit lymphokine production and release
use for immune-mediate problems of lids, conj, cornea (KCS, pannus, episcleritis)
KCS common, painful, sight-threatening
post corneal transplantation |
|
|
Term
Cylosporine
clinical effects |
|
Definition
most common tx for KCS
reverses immune-mediated changes to lacrimal gland (eventually)
stimulates tear production (lacrostimulation)-increase tear quantity and quality
reverse inflammatory changes in conj and cornea-slow
legal issues (still under patent), safety issues (gloves, wash hands) |
|
|
Term
|
Definition
used to stop devastating effects of proteinases (collagenases and gelatinases) on cornea
keratomalacia (melting cornea) commonly caused by infection
No ophthalmic prep |
|
|
Term
|
Definition
Serum
N-Acetylcysteine
EDTA 1%
Tetracycline |
|
|
Term
|
Definition
Antiproteolitic properties-collagenase and gelatinases
due to presence of macroglobulins
has epitheliotrophic properties
promote corneal healing |
|
|
Term
Anti protease
N-Acetylcysteine |
|
Definition
5%-10%
irritating
lower concentration
no effect on gelatinases
short shelf life |
|
|
Term
|
Definition
1%
irritating to eye
cheap
limited data on clinical effectiveness |
|
|
Term
Antiprotease
Tetracycline |
|
Definition
concentrates in cornea following topical or systemic admin
chelation
inhibition of gene expression |
|
|
Term
|
Definition
Autonomic innervation of eye is primarily to iris, ciliary body, upper eyelid and orbital cone
arterioles in uvea
used:
Manipulate pupil
limit aqueous production
facilitate outflow of aqeous
mostly anti-gluacoma drugs |
|
|
Term
Parasympathomimetics (miotics)
Direct acting |
|
Definition
cholinergic
directly stimulate Ach receptor of iris and ciliary body
act at myoneuronal junction (iris sphincter)
causes pupil to constrict (miosis)
produces accommodation, opens drainage angle
dilates blood vessels of conj and iris, increase vascular permeability
stimulates lacrimation |
|
|
Term
Parasympathomimetics
Inidirect acting |
|
Definition
Cholinesterase inhibitors
inhibit hydrolysis of Ach at nerve ending resulting in prolongues presence of neurotransmitter |
|
|
Term
Direct acting parasympathomimetics
Pilocarpine |
|
Definition
muscarinic
0.5-10% solution or ointment
inexpensive
constricts pupil
glaucoma to facilitate outflow
lacrimomimetic
10 minutes to onset, duration 8 hours |
|
|
Term
Direct acting parasympathomimetics
Pilocarpine
adverse effects |
|
Definition
transient stinging
salivation, vomiting, diarrhea
ciliary spasm= "eye ache"
myopia=near sighted
blurred vision
poor dark adaption
bradycardia, hypotension, bronchospasm |
|
|
Term
Parasympatholytics (Mydriatics) |
|
Definition
Block Ach receptors in iris and ciliary body
Dilate pupil by paralyzing sphincter, dilator is unopposed->mydriasis
ciliary muscle paralysis (cycloplegia)->prevent ciliary muscle spasm induced by uveitis, reduce pain and discomfort
Accomadation is lost due to mydriasis |
|
|
Term
Parasympatholytics (Mydriatics)
uses |
|
Definition
Control miosis cuased by ulcer and uveitis, help with prevention of posterior synechia
reduce pain of smooth muscle spasm in ciliary body and iris caused by corneal ulcers and uveitis
reduce clinical signs of uveitis->reduce vascular permeability
facilitate vision if animal has central corneal opacity or nuclear cataract |
|
|
Term
Parasympatholytics (Mydriatics)
Atropine |
|
Definition
0.5-2% o/s or 1% o/o
inexpensive
onset 30-60 min; recovery 96-120 hr-dog; 60hr-cat
may extend more than 14 days in horse
dose to effect
readily absorved through cornea
affinity for pigmented tissue-iris and ciliary body |
|
|
Term
Parasympatholytics (Mydriatics)
Atropine adverse effects |
|
Definition
affects autonomic nervous system
may cause colic in horses-gut stasis
increased intraocular pressure if narrow angle
blurred vision
dries tears, saliva, gastric secretions
bitter taste causes salivation, nausea (use ointment)
tachycardia |
|
|
Term
Parasympatholytics (Mydriatics)
Tropicamide |
|
Definition
0.5-1% solution
short onset, 15-20 min
duration 3-4 hrs
best mydriatic for eye exam |
|
|
Term
Carbonic anhydrase inhibitors (CAI)
Anti-glaucoma |
|
Definition
topical
block enzyme CA
synergic with Beta blockers
|
|
|
Term
Carbonic anhydrase inhibitors (CAI)
Anti-glaucoma
ophthalmic preps |
|
Definition
dorzolamide 2% o/s
Dorzolamide+Timolol o/s
Brinzolamide 1% o/s (doesn't work well in cats) |
|
|
Term
Prostaglandin analogues
Anti-gluacoma |
|
Definition
Reduce IOP by increasing uveoscleral outflow
cause profound miosis
long lasting-usually SID-BID |
|
|
Term
Prostaglandin analogues
Anti-gluacoma
ophthalmic preps |
|
Definition
Latanoprost 0.005% o/s
Travoprost 0.004% o/s |
|
|